We are live on
!
Find out more
RCM
Rotella Capital Management Portfolio holdings
AUM
$1.47M
1-Year Est. Return
12.32%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-12.32%
3 Year Est. Return
+26.58%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$115M
AUM Growth
+$20.1M
(+21%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
12.95%
Top 10 Holdings %
Top 10 Hldgs %
25.43%
Holding
511
New
200
Increased
86
Reduced
69
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Dividend Appreciation ETF
VIG
|
+$2.32M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$2.03M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$1.67M |
| 4 |
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
|
+$1.6M |
| 5 |
Factset
FDS
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.36M |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$2.34M |
| 3 |
FMC
FMC
|
+$1.93M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.9M |
| 5 |
Mattel
MAT
|
+$1.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 12.17% |
| 2 | Technology | 8.26% |
| 3 | Consumer Staples | 6.36% |
| 4 | Healthcare | 4.58% |
| 5 | Financials | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Boston Scientific
BSX
$71.1B
| $133K | 0.12% |
+10,000
| New | +$128K |
|
|
CIM
202
Chimera Investment
CIM
$1.06B
| $133K | 0.12% |
+2,787
| New | +$135K |
|
203
NLI Holdings
NL
$286M
| $133K | 0.12% |
+15,455
| New | +$119K |
|
|
UCTT
204
Ultra Clean Holdings
UCTT
$3.79B
| $133K | 0.12% |
+14,377
| New | +$122K |
|
|
ELNK
205
DELISTED
EarthLink Holdings Corp.
ELNK
| $132K | 0.11% |
30,144
-16,200
| -35% | -$63.8K |
|
206
BGC Group
BGC
$5.25B
| $131K | 0.11% |
+22,226
| New | +$119K |
|
|
CALL
207
DELISTED
magicJack VocalTec Ltd
CALL
| $131K | 0.11% |
+16,100
| New | +$139K |
|
208
OraSure Technologies
OSUR
$287M
| $130K | 0.11% |
+12,800
| New | +$115K |
|
|
ESI
209
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
| $129K | 0.11% |
13,400
+1,500
| +13% | +$12.8K |
|
210
Dawson Geophysical
DWSN
$148M
| $128K | 0.11% |
20,785
+9,349
| +82% | +$76.7K |
|
|
BEAT
211
DELISTED
BioTelemetry, Inc.
BEAT
| $125K | 0.11% |
12,479
-3,800
| -23% | -$32.6K |
|
|
NSU
212
DELISTED
Nevsun Resources Ltd.
NSU
| $125K | 0.11% |
32,500
-31,000
| -49% | -$113K |
|
213
Nordic American Tanker
NAT
$1.33B
| $123K | 0.11% |
12,298
+605
| +5% | +$5.19K |
|
214
Perion Network
PERI
$386M
| $123K | 0.11% |
9,340
+5,873
| +169% | +$93.5K |
|
|
DALN
215
DELISTED
DallasNews
DALN
| $122K | 0.11% |
+2,941
| New | +$137K |
|
216
Veru
VERU
$38M
| $122K | 0.11% |
+3,125
| New | +$129K |
|
|
NCIT
217
DELISTED
NCI, Inc.
NCIT
| $122K | 0.11% |
11,944
-3,800
| -24% | -$40K |
|
218
FormFactor
FORM
$9.38B
| $120K | 0.1% |
+14,009
| New | +$110K |
|
219
Star Group
SGU
$420M
| $120K | 0.1% |
19,597
-15,235
| -44% | -$93K |
|
220
Alpha and Omega Semiconductor
AOSL
$1.01B
| $119K | 0.1% |
+13,422
| New | +$120K |
|
221
Harvard Bioscience
HBIO
$28.5M
| $119K | 0.1% |
2,095
-1,086
| -34% | -$51.8K |
|
222
Iridium Communications
IRDM
$5.26B
| $119K | 0.1% |
+12,200
| New | +$114K |
|
|
DSPG
223
DELISTED
DSP Group Inc
DSPG
| $119K | 0.1% |
10,977
-699
| -6% | -$7.19K |
|
224
MBIA
MBI
$268M
| $118K | 0.1% |
+12,400
| New | +$120K |
|
|
ARTX
225
DELISTED
Arotech Corporation
ARTX
| $118K | 0.1% |
50,728
+26,200
| +107% | +$68.1K |
|
Similar funds
LCM
USO
IVMX
GOCM
TBAM
KCP
LWA
LPPI
Rotella Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Rotella Capital Management held 511 positions worth $115M, up 21% from $95.3M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Rotella Capital Management deployed $14.9M of net new capital in Q4 2014, opening 200 new positions and adding to 86 existing holdings. Its largest new stake was BIO-REFERENCE LABS INC-NEW-: 55,212 shares worth $1.77M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, up from 8% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $2.36M trimmed.
- Rotella Capital Management's largest Q4 2014 buy was BIO-REFERENCE LABS INC-NEW-: 55,212 shares worth $1.77M.
- Rotella Capital Management added most to Vanguard Dividend Appreciation ETF in Q4 2014, an estimated $2.32M increase.
- Rotella Capital Management's biggest Q4 2014 reduction was Vanguard Total Bond Market, cutting an estimated $2.36M.
- Rotella Capital Management fully exited FMC in Q4 2014, selling an estimated $1.93M.
- Rotella Capital Management's ten largest holdings make up 25% of its $115M portfolio in Q4 2014.
- Rotella Capital Management opened 200 new positions and closed 149 in Q4 2014.
- Rotella Capital Management's portfolio value rose 21% quarter-over-quarter to $115M.
Based on Rotella Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.